Medichem
Medichem Co., Ltd., headquartered in South Korea (KR), is a prominent player in the pharmaceutical and chemical industries. Founded in 1995, the company has established itself as a leader in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates, serving a global market with a strong presence in Asia, Europe, and North America. Medichem is renowned for its commitment to quality and innovation, offering a diverse range of products that cater to various therapeutic areas. The company’s state-of-the-art facilities and adherence to stringent regulatory standards set it apart in a competitive landscape. With a focus on sustainability and customer satisfaction, Medichem has achieved significant milestones, solidifying its market position as a trusted partner in the pharmaceutical supply chain.
DitchCarbon Score
How does Medichem's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medichem's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medichem's reported carbon emissions
Medichem, headquartered in South Korea (KR), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Despite the absence of detailed emissions data, it is important to note that Medichem is committed to addressing climate change through various initiatives. However, no specific reduction targets or climate pledges have been disclosed. This lack of information suggests that while the company may be aware of the importance of sustainability, further transparency regarding their carbon footprint and climate commitments would be beneficial for stakeholders and the industry at large. In the context of the pharmaceutical and chemical sectors, companies are increasingly expected to set ambitious targets for reducing greenhouse gas emissions and to align with global climate goals. Medichem's future commitments in this area will be crucial for its reputation and operational sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medichem is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
